Bronchoconstriction following nebulised colistin in cystic fibrosis

Archives of Disease in Childhood
S CunninghamC Wallis

Abstract

Nebulised colistin is regularly used as antipseudomonal therapy in children with cystic fibrosis. We assessed bronchoconstriction in response to nebulised colistin in 58 children. Nebulised colistin significantly reduced FEV(1), MEF(25%), and SaO(2) for 15 minutes. In 20 children the reduction was greater than 10% from baseline FEV(1), and was still at that level in five at 30 minutes. Subjective assessment, baseline FEV(1), and serum IgE were unable to identify susceptible children. It is recommended that children receiving colistin should be carefully assessed for bronchoconstriction.

Citations

Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E Falagas, Sofia K Kasiakou
Aug 9, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter K Linden, David L Paterson
Nov 14, 2001·Current Opinion in Pulmonary Medicine·P Beringer
Jul 9, 2008·Antimicrobial Agents and Chemotherapy·Stephanie J WallaceRoger L Nation
Jul 16, 2008·Clinical Microbiology Reviews·David LandmanJohn Quale
Jul 24, 2001·Archives of Disease in Childhood·K ArmonU Werneke
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonBonnie W Ramsey
Feb 8, 2005·Critical Care : the Official Journal of the Critical Care Forum·Argyris MichalopoulosMatthew E Falagas
Feb 16, 2012·Expert Opinion on Drug Delivery·Sabina Antonela Antoniu, Ileana Cojocaru
May 6, 2010·Chest·Susana Gómez-OllésXavier Muñoz
Jan 22, 2004·Chest·James R YankaskasDavid Rodman
Feb 12, 2005·Chest·Ghassan A AlothmanAllan L Coates
Nov 3, 2010·International Journal of Pediatric Otorhinolaryngology·Hanan M IbrahimS R Abu-Ata
Oct 30, 2009·Burns : Journal of the International Society for Burn Injuries·H GanapathyP Dziewulski
Jan 27, 2009·International Journal of Antimicrobial Agents·Matthew E FalagasPetros I Rafailidis
Jan 31, 2006·The Journal of Infection·Said MotaouakkilMohamed Benbachir
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·E M WestermanH G M Heijerman
Jun 30, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Harry HeijermanUNKNOWN consensus working group
Oct 11, 2016·Expert Review of Respiratory Medicine·Peter J Barry, Patrick A Flume
Dec 7, 2016·Expert Review of Anti-infective Therapy·G PoulakouG Dimopoulos
May 5, 2009·Chronic Respiratory Disease·T W R Lee
Nov 11, 2005·Chronic Respiratory Disease·S P Conway
Oct 3, 2006·Expert Review of Anti-infective Therapy·Helen Giamarellou
Dec 5, 2006·Expert Review of Anti-infective Therapy·Valerie Waters, Felix Ratjen
Mar 21, 2009·Expert Review of Molecular Diagnostics·Gaudenz M HafenPhilipp Latzin
May 19, 2010·Expert Review of Respiratory Medicine·Steven P Conway, Tim Wr Lee
Nov 26, 2009·Expert Opinion on Pharmacotherapy·José MolinaJerónimo Pachón
May 17, 2017·International Journal of Molecular Sciences·Diego J MaselliMarcos I Restrepo
Jul 26, 2017·Drugs·Garyphallia PoulakouGeorge Dimopoulos
Jan 22, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·David BerlanaR Jódar
Feb 26, 2021·Pharmacological Reviews·Sue C NangJian Li
May 27, 2016·Clinical Microbiology Reviews·Eric WenzlerLarry H Danziger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.